The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness

The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness

Authors

DOI:

https://doi.org/10.7175/fe.v23i1.1522

Keywords:

influenza vaccine, Vaccine effectiveness, Real-world evidence

References

Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol 2018; 16: 47-60; https://doi.org/10.1038/nrmicro.2017.118

World Health Organization - Regional Office for Europe. Influenza - estimating burden of disease. Available at: https://www.euro.who.int/en/health-topics/communicable-diseases/influenza/seasonal-influenza/burden-of-influenza (last accessed on January 2022)

D’Angiolella LS, Lafranconi A, Cortesi PA, et al. Costs and effectiveness of influenza vaccination: a systematic review. Ann Ist Super Sanita 2018; 54: 49-57; https://doi.org/10.4415/ANN_18_01_10

Treanor JJ. Influenza (Including Avian Influenza and Swine Influenza). In: Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases (Eighth Edition). W.B. Saunders, 2015: Pages 2000-2024.e6; https://doi.org/10.1016/B978-1-4557-4801-3.00167-3

US Centers for Disease Control and Prevention – National Center for Immunization and Respiratory Diseases (NCIRD). How Flu Vaccine Effectiveness and Efficacy are Measured. Available at: https://www.cdc.gov/flu/vaccines-work/effectivenessqa.htm (last accessed on January 2022)

Balasingam S, Wilder-Smith A. Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies. Int J Infect Dis 2016; 49: 18-29; https://doi.org/10.1016/j.ijid.2016.05.013

Boni MF. Vaccination and antigenic drift in influenza. Vaccine 2008; 26: C8-14; https://doi.org/10.1016/j.vaccine.2008.04.011

US Centers for Disease Control and Prevention - National Center for Immunization and Respiratory Diseases (NCIRD). Influenza Vaccines for Older Adults. Advisory Committee on Immunization Practices (ACIP) January 12, 2022

Jayasundara K, Soobiah C, Thommes E, et al. Natural attack rate of influenza in unvaccinated children and adults: a meta-regression analysis. BMC Infectious Diseases 2014; 14: 670; https://doi.org/10.1186/s12879-014-0670-5

Tokars JI, Rolfes MA, Foppa IM, et al.. An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States. Vaccine 2018; 36: 7331-7; https://doi.org/10.1016/j.vaccine.2018.10.026

Flannery B, Fry AM. Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies. J Infect Dis 2019; 220: 1237-9; https://doi.org/10.1093/infdis/jiy717

Halloran ME, Struchiner CJ, Longini IM. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol 1997; 146: 789-803; https://doi.org/10.1093/oxfordjournals.aje.a009196

Heneghan C, Goldacre B, Mahtani KR. Why clinical trial outcomes fail to translate into benefits for patients. Trials 2017; 18: 122; https://doi.org/10.1186/s13063-017-1870-2

Martini N, Trifirò G, Capuano A, et al. Expert opinion on Real-World Evidence (RWE) in drug development and usage. Pharmadvances 2020; 2: 41-50; https://doi.org/10.36118/pharmadvances.02.2020.01

Uyeki TM. High-risk Groups for Influenza Complications. JAMA 2020; 324: 2334; https://doi.org/10.1001/jama.2020.21869

Ponticelli D, Madotto F, Conti S, et al. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up. Intern Emerg Med 2021: 1-6; https://doi.org/10.1007/s11739-021-02857-y

Ponticelli D, Antonazzo IC, Caci G, et al. Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months. J Travel Med 2021; 28: taab173; https://doi.org/10.1093/jtm/taab173

Ferrara P, Antonazzo IC, Polosa R. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: A 3-month follow-up-Reply. Intern Emerg Med 2022; 17: 313-14; https://doi.org/10.1007/s11739-021-02911-9

US Food and Drug Administration. Real-World Evidence. FDA: 2022. Available at: https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence (last accessed on January 2022)

Reynolds MW, Bourke A, Dreyer AN. Considerations when evaluating real-world data quality in the context of fitness for purpose. Pharmacoepidemiol Drug Saf 2020; 29: 1316-8; https://doi.org/10.1002/pds.5010

Schünemann , Brożek J, Guyatt G, et al. GRADE Handbook. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013. Available at: https://gdt.gradepro.org/app/handbook/handbook.html (last accessed on January 2022)

Downloads

Published

2022-03-03

How to Cite

Ferrara, P., & Mantovani, L. G. (2022). The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness. Farmeconomia. Health Economics and Therapeutic Pathways, 23(1). https://doi.org/10.7175/fe.v23i1.1522

Issue

Section

Editorial

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >> 
Loading...